Author Question: Which of the following is an indication for use of an adrenergic bronchodilator? a. Treatment of ... (Read 48 times)

ereecah

  • Hero Member
  • *****
  • Posts: 530
Which of the following is an indication for use of an adrenergic bronchodilator?
 
  a. Treatment of excessive, viscous mucus secretions
  b. Antiinflammatory treatment of mild to moderate persistent asthma
  c. Treatment of reversible airflow obstruction
  d. Prophylactic management of asthma

Question 2

Adrenergic bronchodilators improve flow rates for which of the following diseases? 1. Asthma 2. Acute bronchitis 3. Chronic bronchitis 4. Pulmonary fibrosis
 
  a. 1 only
  b. 1, 2, and 3 only
  c. 2, 3, and 4 only
  d. 1, 2, 3, and 4



Jsherida

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

ANS: C
The general indication for use of an adrenergic bronchodilator is the presence of reversible air-flow obstruction.

Answer to Question 2

ANS: B
The most common use of these agents clinically is to improve flow rates in asthma (including ex-ercise-induced asthma), acute and chronic bronchitis, emphysema, bronchiectasis, cystic fibrosis, and other obstructive airway states.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

The B-complex vitamins and vitamin C are not stored in the body and must be replaced each day.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library